Implenia
CHF 65.30Change from previous close: +1.56%Absolute change: +CHF 1.00
Valuation
Data as of October 4, 2026
Valuation multiples
- Market cap
- CHF 1.21B
- Enterprise value
- CHF 1.62B
- P/E (trailing 12 months)
- 14.4
- Forward P/E
- 11.6
- PEG
- 2.78
- Price/book
- 1.61
- Price/sales
- 0.36
- EV/EBITDA
- 14.0
- EV/revenue
- 0.48
Profitability and growth
- Gross margin
- 45.2%
- Operating margin
- 1.3%
- Net margin
- 2.5%
- ROE
- 12.3%
- ROA
- 1.2%
- Revenue growth (year over year)
- -4.8%
- Earnings growth (year over year)
- 0.0%
Financial health
- Total cash
- CHF 376.62M
- Total debt
- CHF 788.58M
- Debt/equity
- 1.04
- Current ratio
- 1.25
- Quick ratio
- 1.09
Dividends
- Annual dividend per share
- CHF 1.40
- Dividend yield
- 2.1%
- Payout ratio
- 30.9%
- Ex-dividend date
- April 2, 2026
Analysts and estimates
- Average price target
- CHF 88.00
- Median price target
- CHF 90.00
- High price target
- CHF 100.00
- Low price target
- CHF 75.00
- Analysts with a price target
- 5
- Forward EPS
- CHF 5.64
- EPS estimate, current year
- CHF 4.56
Shares and trading
- Beta
- 0.41
- Average volume
- 46.1K
- Shares outstanding
- 18.47M
- Float
- 16.36M
- Institutional ownership
- 47.4%
- Insider ownership
- 11.4%